Publication & Citation Trends
Publications
0 total
Genetic modifiers of APOE-ε4-associated cognitive decline
Cited by 0
Semantic Scholar
Association between Plasma P-tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease.
Cited by 0
Semantic Scholar
Characterizing early symptomatic AD patients by visual and quantitative tau profiles
Cited by 0
Semantic Scholar
Towards Identifying an Optimal Time for Amyloid Assessment with Donanemab Treatment (S23.004)
Cited by 0
Semantic Scholar
Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction OA
Cited by 32
Semantic Scholar
Analytical Validation and Performance of a Blood-Based P-tau217 Diagnostic Test for Alzheimer Disease.
Cited by 6
Semantic Scholar
Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease
Cited by 3
Semantic Scholar
Tau PET and Plasma p‐tau217 as Independent and Synergistic Predictors of Clinical Progression in Early Symptomatic AD Patients With Amyloid and Tau Pathology
Cited by 0
Semantic Scholar
Association of Occipital Amyloid PET Burden with ARIA‐E: Exploratory Analyses in Three Clinical Trials of Donanemab
Cited by 1
Semantic Scholar
Alzheimer's Imaging Consortium.
Cited by 0
Semantic Scholar
Research Topics
Dementia and Cognitive Impairment Research
(207)
Alzheimer's disease research and treatments
(181)
Medical Imaging Techniques and Applications
(108)
Functional Brain Connectivity Studies
(101)
Advanced Neuroimaging Techniques and Applications
(43)
Affiliations
West Virginia University
National Institute on Drug Abuse
MACOM (United States)
Harvard University
Reata Pharmaceuticals (United States)